{"id":"W2559200630","doi":"10.1182/blood.v116.21.4669.4669","title":"Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clinical endpoint; Adverse effect; Internal medicine; Bleeding diathesis; Immune thrombocytopenia; Clinical trial; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002590642,0.000468042,0.0009913062,0.0002053285,0.0002377447,0.0004578616,0.0002633209,0.0008383668,0.001388644],"category_scores_gemma":[0.0009429092,0.0002030108,0.0006530729,0.0001823171,0.0005176212,0.0003032586,0.0001892482,0.0009724091,0.0003338108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002490529,"about_ca_system_score_gemma":0.0006244039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003612631,"about_ca_topic_score_gemma":0.0004588792,"domain_scores_codex":[0.999317,0.0004456005,0.00004374169,0.00005423298,0.00007146265,0.00006791775],"domain_scores_gemma":[0.9989913,0.0003533292,0.0002526559,0.00007224576,0.00007559465,0.0002547993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7750157,0.03874391,0.04324378,0.0006971469,0.0006449935,0.000311845,0.0002317413,0.001012077,0.05357717,0.0001844984,0.0007223709,0.08561479],"study_design_scores_gemma":[0.118342,0.831719,0.04334005,0.00003568299,0.0002217215,0.0001865749,0.00005846874,0.0007611924,0.003875316,0.00006756501,0.001375281,0.00001723839],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997548,0.0009661763,0.0002040509,0.00004530096,0.00002101162,0.0005350736,0.0001208752,0.00001504008,0.0005444124],"genre_scores_gemma":[0.9976689,0.0004365064,0.0004464413,0.0001975132,0.0000766956,0.0004783743,0.0002414546,0.000003373081,0.0004506223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002590642,"threshold_uncertainty_score":0.01370078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007279425791655949,"score_gpt":0.2592700842792749,"score_spread":0.2519906584876189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}